Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect

Table 2

Pentosidine, CML, and sRAGE levels in control subjects and patients with MetS.

	Control subjects	Patients
Pentosidine (pmol/mL)	53.15 (36.61–60.34)	211.21 (69.94–379.89)	<0.001
CML (pg/mL)	171.75 (81.03–298.06)	440.38 (383.98–601.36)	<0.001
sRAGE (pg/mL)	117.33 (104.38–158.04)	155 (126.34–240.4)	0.014

Values are median (25%–75%) percentiles; CML: N (carboxymethyl) lysine; MetS: metabolic syndrome; sRAGE: soluble receptor for AGE.